Tempus Wealth Planning LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 7.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,131 shares of the exchange traded fund’s stock after purchasing an additional 301 shares during the period. […]